Collegium Pharmaceutical (COLL) EBITDA Margin Growth (3y) (2019 - 2026)
Collegium Pharmaceutical (COLL) EBITDA Margin Growth (3y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1,673.00 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -37.00 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -5,395.00 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -1,442.00 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -1,299.00 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 5,091.00 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 5,193.00 |
| 10 | Collegium Pharmaceutical | 1.14 Bn | 853.50 Mn | 117.25 Mn | -105.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -105.00 |
| Dec 31, 2025 | 2,121.00 |
| Sep 30, 2025 | 1,354.00 |
| Jun 30, 2025 | 968.00 |
| Mar 31, 2025 | 2,416.00 |
| Dec 31, 2024 | 19,137.00 |
| Sep 30, 2024 | 392.00 |
| Jun 30, 2024 | 1,289.00 |
| Mar 31, 2024 | 998.00 |
| Dec 31, 2023 | 2,153.00 |
| Sep 30, 2023 | 814.00 |
| Jun 30, 2023 | 509.00 |
| Mar 31, 2023 | 1,040.00 |
| Dec 31, 2022 | 1,156.00 |
| Sep 30, 2022 | 2,485.00 |
| Jun 30, 2022 | 1,567.00 |
| Mar 31, 2022 | 145.00 |
| Dec 31, 2021 | -10,401.00 |
| Sep 30, 2021 | 3,389.00 |
| Jun 30, 2021 | 2,977.00 |